Empowered Funds’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10M | Sell |
216,147
-75,707
| -26% | -$3.5M | 0.11% | 199 |
|
|
2025
Q1 | $17.8M | Sell |
291,854
-2,089
| -0.7% | -$127K | 0.25% | 70 |
|
|
2024
Q4 | $16.6M | Buy |
293,943
+250,451
| +576% | +$14.2M | 0.24% | 67 |
|
|
2024
Q3 | $2.25M | Sell |
43,492
-5,331
| -11% | -$276K | 0.04% | 633 |
|
|
2024
Q2 | $2.03M | Sell |
48,823
-159,613
| -77% | -$6.63M | 0.04% | 607 |
|
|
2024
Q1 | $11.3M | Buy |
208,436
+35,802
| +21% | +$1.94M | 0.2% | 100 |
|
|
2023
Q4 | $8.86M | Buy |
172,634
+78,822
| +84% | +$4.04M | 0.22% | 91 |
|
|
2023
Q3 | $5.44M | Buy |
93,812
+54,233
| +137% | +$3.15M | 0.16% | 151 |
|
|
2023
Q2 | $2.53M | Buy |
39,579
+9,573
| +32% | +$612K | 0.09% | 323 |
|
|
2023
Q1 | $2.08M | Buy |
30,006
+6,480
| +28% | +$449K | 0.12% | 203 |
|
|
2022
Q4 | $1.69M | Buy |
23,526
+7,366
| +46% | +$530K | 0.11% | 103 |
|
|
2022
Q3 | $1.15M | Buy |
16,160
+3,210
| +25% | +$228K | 0.11% | 153 |
|
|
2022
Q2 | $997K | Sell |
12,950
-729
| -5% | -$56.1K | 0.13% | 169 |
|
|
2022
Q1 | $999K | Buy |
+13,679
| New | +$999K | 0.11% | 186 |
|
|
2021
Q4 | – | Sell |
-9,181
| Closed | -$543K | – | 252 |
|
|
2021
Q3 | $543K | Buy |
9,181
+4,062
| +79% | +$240K | 0.07% | 169 |
|
|
2021
Q2 | $340K | Buy |
+5,119
| New | +$340K | 0.04% | 185 |
|
|
2020
Q3 | – | Sell |
-20,099
| Closed | -$1.18M | – | 111 |
|
|
2020
Q2 | $1.18M | Buy |
+20,099
| New | +$1.18M | 0.46% | 95 |
|
|
2019
Q3 | – | Sell |
-46,376
| Closed | -$2.1M | – | 101 |
|
|
2019
Q2 | $2.1M | Buy |
+46,376
| New | +$2.1M | 0.88% | 40 |
|